Live
Endpoints NewsParabilis reveals IPO plans the day after Regeneron deal as listings heat upEndpoints NewsGHO Capital, CBC Group to merge, forming what could be the largest healthcare specialist investorFierceBiotechParabilis, fresh from inking Regeneron pact, plans IPO to fund tumor drug’s phase 3 pushFierceBiotechPfizer furthers pneumococcal efforts, remains ‘comfortable’ taking on emerging threats: vaccine chiefLabiotechEight Swedish companies spearheading the country’s biotech sceneeLifeTwelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filamentsIlluminaIllumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - TradingViewIlluminaIllumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - PR NewswireEndpoints NewsTrumpRx adds hundreds of generic medicines to siteClinical OMICsSmart Wristband Detects Cardiac Arrest with 92% Sensitivity in Early Clinical StudyEndpoints NewsAnother Paragon offshoot chooses reverse merger, this time for migraine drugs10x Genomics BlogWhy 10x Genomics Stock Is Surging Today - TipRanks

Archive

Latest Oldest
Total 11567
Page 530 / 643
Query --